CN105288433A - 一种用于放射性直肠炎治疗与护理的中药组方 - Google Patents
一种用于放射性直肠炎治疗与护理的中药组方 Download PDFInfo
- Publication number
- CN105288433A CN105288433A CN201510874373.6A CN201510874373A CN105288433A CN 105288433 A CN105288433 A CN 105288433A CN 201510874373 A CN201510874373 A CN 201510874373A CN 105288433 A CN105288433 A CN 105288433A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- radix
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 230000000474 nursing effect Effects 0.000 title claims abstract description 8
- 206010017912 Gastroenteritis radiation Diseases 0.000 title abstract 3
- 208000020624 radiation proctitis Diseases 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 206010036774 Proctitis Diseases 0.000 claims description 21
- 230000005855 radiation Effects 0.000 claims description 20
- 239000004615 ingredient Substances 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 24
- 210000000952 spleen Anatomy 0.000 abstract description 21
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract description 11
- 210000000582 semen Anatomy 0.000 abstract description 10
- 230000001154 acute effect Effects 0.000 abstract description 6
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 235000008216 herbs Nutrition 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000229182 Ledebouriella seseloides Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 235000019606 astringent taste Nutrition 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 38
- 239000008280 blood Substances 0.000 description 38
- 210000000214 mouth Anatomy 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 20
- 241000628997 Flos Species 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 238000001959 radiotherapy Methods 0.000 description 13
- 206010012735 Diarrhoea Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 208000001848 dysentery Diseases 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 230000000968 intestinal effect Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 238000012790 confirmation Methods 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 208000004998 Abdominal Pain Diseases 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 7
- 208000033809 Suppuration Diseases 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 208000035861 hematochezia Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 208000028659 discharge Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 241001092084 Agrimonia Species 0.000 description 4
- 235000016993 Agrimonia Nutrition 0.000 description 4
- 241000726094 Aristolochia Species 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 241001180876 Saposhnikovia Species 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 241000722081 Stellaria <angiosperm> Species 0.000 description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 201000010881 cervical cancer Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 210000000664 rectum Anatomy 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010016807 Fluid retention Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010057071 Rectal tenesmus Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 210000002255 anal canal Anatomy 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000001217 buttock Anatomy 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 239000002934 diuretic Substances 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000012271 tenesmus Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 241000223238 Trichophyton Species 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010061424 Anal cancer Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000792859 Enema Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010054828 Rectal lesion Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000001800 adrenalinergic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 201000007696 anal canal cancer Diseases 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 235000021270 cold food Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000095 emetic effect Effects 0.000 description 1
- 239000007920 enema Substances 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 201000007772 internal hemorrhoid Diseases 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000292 leukogenic effect Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 201000001514 prostate carcinoma Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000002579 sigmoidoscopy Methods 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于放射性直肠炎治疗与护理的中药组方,属中药领域。本发明药物有效成分的原料药组成以及重量份数为:地榆72~99份、土茯苓71~97份、防风69~94份、厚朴64~89份、枳壳63~86份、薏苡仁60~83份、银柴胡55~80份、仙鹤草53~77份、白芍48~75份、白术47~72份、陈皮44~68份、黄柏39~64份、槐花39~63份、青木香36~60份、当归33~55份、三棱28~52份、红花27~52份、砂仁22~48份、甘草20~46份。本发明经大量临床验证,具有清热解毒、健脾祛湿、祛瘀通络、固涩收敛的良好效果,可广泛适用于治疗急、慢性放射性直肠炎患者。
Description
技术领域
本发明涉及中药领域,尤其涉及一种用于放射性直肠炎治疗与护理的中药组方。
背景技术
放射性直肠炎是盆腔肿瘤接受放射治疗后常见的急性和慢性并发症,发病率高,约6.4%-21.6%,多数患者病程迁延不愈,约30%患者因症状严重被迫中断放疗计划,严重影响肿瘤局控率及患者的生活质量。
当盆腔附近肿瘤应用放射性镭、钴、铯等进行照射治疗,这些放射性原素对癌有抑制作用,对正常组织也有损害,损害直肠粘膜时,可造成放射性直肠炎。所以因放射治疗造成的放射性直肠炎,是临床上较多见的。文献报道宫颈癌体外照射结合腔内高剂量率放射治疗时,中、重度放射性直肠炎的发生率约为5.3~15.6%。
放射性直肠炎的症状表现为直肠流血,为鲜红或暗红色,多在排便时流出,一般是少量出血,偶尔大量出血。破溃后有坏死组织脱落排出,有臭味,肛门直肠部酸痛或灼痛,以后因括约肌受刺激而出现里急后重。症状表现是充血水肿性的,可以是糜烂溃疡性的,也可以是溃疡出血性的;可以引起疼痛,出血,并会引起直肠流脓和黏液。
放射性直肠炎的早期症状表现为由于神经系统对放射线的反应,早期即可出现胃肠道的症状。一般多出现在放疗开始后1~2周内。恶心、呕吐、腹泻、排出粘液或血样便。累及直肠者伴有里急后重。持久便血可引起缺铁性贫血。便秘少见。偶有低热。腹痛型肠易激综合症则提示小肠受累,乙状结肠镜检查可见粘膜水肿、充血,严重者可有糜烂或溃疡。
放射性直肠炎的晚期症状表现为急性期的症状迁延不愈或直至放疗结束6个月至数年后始有显著症状者,均提示病变延续,终将发展引起纤维化或狭窄。此期内的症状,早的可在放疗后半年,晚的可在10年后甚至30年后才发生,多与肠壁血管炎以及后续病变有关。
西医治疗放射性直肠炎通常采用激素类药物,实际应用中往往因患者病情不同,而导致各种严重的副作用,中医药防治放射性直肠炎症状缓解率高、副作用小,显示出了一定的优势,但研究水平较低,无成型固定的专方专药,不便于推广使用。现有技术中的药物组合物也往往不尽如人意,例如常表现出疗效不够显著、作用单一、用量大、成本高等缺点。因此,开发新型高效的可用于治疗放射性直肠炎的药物组合物成为本发明的研究宗旨所在。
发明内容
为获得新型高效的可用于治疗放射性直肠炎的中药物组合物,本发明人对此经过大量的深入研究,在付出了充分的创造性劳动后,从而完成了本发明。本发明的技术方案实施如下:
所述药物有效成分的原料药组成及重量份数为:
地榆72~99份土茯苓71~97份防风69~94份厚朴64~89份
枳壳63~86份薏苡仁60~83份银柴胡55~80份仙鹤草53~77份
白芍48~75份白术47~72份陈皮44~68份黄柏39~64份
槐花39~63份青木香36~60份当归33~55份三棱28~52份
红花27~52份砂仁22~48份甘草20~46份。
所述药物有效成分的原料药组成及重量份数为:
地榆79~94份土茯苓76~90份防风72~87份厚朴71~86份
枳壳67~80份薏苡仁64~78份银柴胡61~75份仙鹤草58~72份
白芍54~68份白术50~67份陈皮48~63份黄柏45~60份
槐花41~58份青木香40~54份当归35~53份三棱35~50份
红花31~47份砂仁26~43份甘草25~39份。
所述药物有效成分的原料药组成及重量份数为:
地榆78~88份土茯苓76~84份防风74~83份厚朴70~78份
枳壳67~75份薏苡仁64~72份银柴胡59~71份仙鹤草57~68份
白芍54~65份白术52~62份陈皮48~58份黄柏44~55份
槐花44~51份青木香40~48份当归35~47份三棱32~45份
红花29~39份砂仁29~38份甘草26~34份。
所述药物有效成分的原料药组成及重量份数为:
地榆85份土茯苓81份防风79份厚朴76份
枳壳72份薏苡仁68份银柴胡65份仙鹤草61份
白芍59份白术58份陈皮53份黄柏49份
槐花49份青木香43份当归42份三棱38份
红花35份砂仁34份甘草31份。
所述药物的制备及使用:
1)按照上述重量份数称取各类药材,混合均匀后加入300ml水,煎煮2次,滤掉药渣即得所述中药组合物汤剂。
2)将步骤1)所得的汤剂取250ml,早晚各服用100ml,余下50ml加温至38℃~40℃于晚间睡前患者排空大便后灌肠。灌肠时取左侧卧位,臀部抬高约10cm,肛管插入10-15cm,将上述50ml药液灌入。灌肠后用消毒纱布置于肛门处以防药液流出,保留30min以上,每晚一次。
3)用药疗程为10天1疗程,巩固治疗需要2-3疗程。
本发明所用中药的药性如下:
地榆:味苦;酸;性寒,无毒。入肝;肺;肾;大肠经。凉血止血;清热解毒;消肿敛疮。主治吐血;咯血;衄血;尿血;便血;痔血;血痢;崩漏;赤白带下;疮痈肿痛;湿疹;阴痒;水火烫烧;蛇虫咬伤。《别录》载:“止脓血,诸痿,恶疮,消酒,除消渴,补绝伤,产后内塞,可作金疮膏,主内漏不止,血不足。”现代医学研究证实,地榆含有大量鞣质,有较强的收敛性,能收缩血管,降低血管的通透性,减少炎性渗出,同时还有明显的杀菌作用,能对抗绿脓杆菌感染。
土茯苓:味甘;淡;性平。入肝;胃;脾经。清热除湿;泄浊解毒;通利关节。主治梅毒;淋浊;泄泻;筋骨挛痛;脚气;痈肿;疮癣;瘰疬;瘿瘤及汞中毒。《纲目》载:“健脾胃,强筋骨,去风湿,利关节,止泄泻。治拘挛骨痛,恶疮痈肿,解汞粉、银朱毒。”
防风:味辛;微甘;性微温。归肺;膀胱;肝;脾经。发表;祛风;胜湿;止痛。主治风寒感冒;感冒夹湿;头痛;昏眩;寒湿腹痛;泄泻;风湿痹痛;四肢拘挛;破伤风;目赤;疮疡;疝瘕;疥癣;风疹。《日华子本草》载:“治三十六般风,男子一切劳劣,补中益神,风赤眼,止泪及瘫缓,通利五脏关脉,五劳七伤,羸损盗汗,心烦体重,能安神定志,匀气脉。”现代医学研究证实,防风能显著提高急性脑缺氧的耐缺氧能力,显著抑制体外诱发的脂质过氧化物的形成,具有抗氧化活性,对神经细胞起保护作用。
厚朴:味苦;辛;性温。入脾;胃;大肠经。行气消积;燥湿除满;降逆平喘。主治食积气滞;腹胀便秘;湿阻中焦;脘痞吐泻;痰壅气逆;胸满咳喘。《别录》载:“温中益气,消痰下气。疗霍乱及腹痛胀满,胃中冷逆及胸中呕不止,泄痢淋露,除惊,去留热心烦满,厚肠胃。”现代医学研究证实,厚朴具有影响胃肠活动,抗菌,抗病毒,抗变态反应,松驰肌肉,抑制中枢神经,抗过敏和维持调节口腔细菌的作用。
枳壳:味苦;酸;性微寒。入肺;脾;肝;胃;大肠经。理气宽胸;行滞消积。主治胸隔痞满;胁肋胀痛;食积不化;脘腹胀满;下痢后重;脱肛;子宫脱垂。《纲目》载:“治胸痹痞满,以枳实为要药,诸方治下血痔痢,大肠秘塞,里急后重,又以枳壳为通用,则枳实不独治下,枳壳不独治高也。”临床医学研究表明,枳壳有显著的抗病原微生物的作用,抑制变态反应,此外还有镇静、利尿、兴奋子宫、强心、升压、利胆等功效。
薏苡仁:味甘;淡;性微寒。入脾;肺;肾经。利湿健脾;舒筋除痹;清热排脓。主治水肿;脚气;小便淋沥;湿温病;泄泻带下;风湿痹痛;筋脉拘挛;肺痈;扁平疣。《本草正》载:“味甘淡,气微凉,性微降而渗,故能去湿利水,以其志湿,故能利关节,除脚气,治痿弱拘挛湿痹,消水肿疼痛,利小便热淋,亦杀蛔虫。以其微降,故亦治咳嗽睡脓,利膈开胃。以其性凉,故能清热,止烦渴、上气。”现代医学研究发现,薏苡仁是一种热稳定的胰蛋白酶抑制剂,有显著的抗肿瘤作用,降血糖、血钙、血压,对子宫颈癌及腹水型肝癌实体瘤有明显抑制作用,此外还有较强的免疫作用。
银柴胡:内服煎汤,或入丸散。
仙鹤草:味苦;涩;性平。入肺;肝;脾经。收敛止血;止痢;杀虫。主治咯血;吐血;尿血;便血;赤白痢疾;崩漏带下;劳伤脱力;痈肿;跌打;创伤出血。《百草镜》载:“下气活血,理百病,散痞满;跌扑吐血,血崩,痢,肠风下血。”现代医学研究证实,仙鹤草为强壮性收敛止血药,抑制纤维蛋白溶酶的活性,有强心、升血压、凝血、止血、凉血、抗菌等作用。内服煎汤;或入散剂。外用捣敷或熬膏涂敷。
白芍:味苦;性平。入肝;脾经。养血柔肝,缓中止痛;敛阴收汗。主治胸腹胁肋疼痛,泻痢腹痛,自汗盗汗,阴虚发热。《别录》载:“通顺血脉,缓中,散恶血,逐贼血,去水气,利膀胱、大小肠,消痈肿,治时行寒热,中恶腹痛,腰痛。”现代医学研究证实,白芍能调节免疫,增强巨噬细胞和白细胞的吞噬功能,调节T淋巴细胞和体液的免疫功能,有保肝、解痉、镇痛、镇静、抗凉、降温作用,此外还对平滑肌有抑制作用,增强耐缺氧、抗氧化和抗疲劳的作用。
白术:味苦;甘;性温。归脾;胃经。健脾益气;燥湿利水;止汗;安胎。主治脾气虚弱;神疲乏力;食少腹胀;大便溏薄;水饮内停;小便不利;水肿;痰饮眩晕;湿痹酸痛;气虚自汗;胎动不安。《本经逢原》载:“术,生用有除湿益燥,消痰利水,治风寒湿痹,死肌痉疸,散腰脐间血,及冲脉为病,逆气里急之功;制熟则有和中补气,止渴生津,止汗除热,进饮食,安胎之效。”现代医学研究证实,白术有强壮和提高机体抗病能力的作用,增强网状内皮系统的吞噬功能,增强白细胞吞噬金黄色葡萄球菌的功能,对白细胞减少症有升白作用,提高淋巴细胞转化率,促进细胞免疫功能,对金黄色葡萄球菌、溶血性链球菌、绿色链球菌、肺炎球菌、脑膜炎球菌、白喉杆菌、枯草杆菌有不同程度的抑制作用,对絮状表皮癣菌、星形奴卡菌、堇色毛癣菌、同心性毛癣菌等皮肤真菌有一定的抑制作用。
陈皮:味辛;甘;性寒。入脾;胃经。下气;调中;化痰;醒酒。主治饮食失调;上气烦满;伤酒口渴。《日华子本草》载:“皮炙作汤,可解酒毒及酒渴,伤寒饮食劳复者,浓煎汁服。”医学临床研究表明,陈皮所含的橙皮苷可抑制胃溃疡,降低毛细血管通透性,具有调整肠胃功能以及抗炎作用,其挥发油具有祛痰、平喘、促进消化液分泌和排除肠内积气等作用,此外还有扩张冠状动脉、降低血压和利胆等作用。
黄柏:味苦;性寒。入肾;膀胱经。清热燥湿;泻火解毒。主治湿热痢疾、泄泻、黄疸;梦遗、淋浊、带下;骨蒸劳热;以及口舌生疮;目赤肿痛;痈疽疮毒;皮肤湿疹。《药品化义》载:“降火能自顶至踵,沦肤彻髓,无不周到,专泻肾与膀胱之火。”现代医学研究证实,黄柏含小蘖碱、黄柏酮等主要成分,有抗菌、收敛、消炎的作用,对各种皮肤湿毒、疮疡等症状,功效良好。
槐花:苦;性微寒。入肝;肺;心;大肠经。凉血止血;清肝明目。主治肠风便血;痔疮下血;血痢;尿血;血淋;崩漏;吐血;衄血;肝热头痛;目赤肿痛;痈肿疮疡。《本草正》载:“凉大肠,杀疳虫。治痈疽疮毒,阴疮湿痒,痔漏,解杨梅恶疮,下疳伏毒。”现代医学研究证实,槐花所含的芸香甙可增强毛细血管抵抗力,改善血管壁脆性,降低血压、抗水肿,对高血压有防止脑血管破裂的功效,此外还有抗炎作用。
青木香:味辛;苦;性寒;有小毒。入肺;胃经。行气止痛;解毒消肿;平肝降压。主治胸胁脘腹疼痛;疝气痛;肠炎;下痢腹痛;咳嗽痰喘;蛇虫咬伤;痈肿疔疮;湿疹;皮肤瘙痒;高血压病。《本草逢原》载:“治大肠,治头风,瘙痒,秃疮。”临床医学研究表明,青木香制剂有一定的降压作用,青木香总生物碱对金黄色葡萄球菌、绿脓杆菌、大肠杆菌及变型杆菌有不同程度的抑制作用,能提高非特异性抗体,增强腹腔巨噬细胞的吞噬活性,增强机体的防御机能,此外还有镇静、催吐作用。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;跌扑损伤;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用,对慢性风湿关节炎急性发作有明显的抑制作用。内服煎汤,酒浸,或入丸散或熬膏。
三棱:味辛;涩;性凉。入肝;脾经。破血行气;消积止痛。主治症瘕痞块;瘀滞经闭;痛经;食积胀痛;跌打伤痛。《日华子本草》载:“治妇人血脉不调,心腹痛,落胎,消恶血,补劳,通月经,治气胀,消扑损瘀血,产后腹痛、血运并宿血不下。”现代医学研究证实,三棱可加强肠管收缩,对子宫有兴奋作用,能抑制血小板聚集、延长血栓形成时间、消融血栓,降低全血粘度。
红花:味辛;性温。入肝;肾经。活血通经,散淤止痛。用于闭经,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。《贵州草药》载:“清热解毒,治无名肿毒,骨折。”现代医学研究证实,红花有提高机体免疫机能、降血压、降血脂、增加冠脉血流量和心肌营养血流量、抑制血栓形成等多种药理作用。
砂仁:味辛;性温。入脾;胃;肾经。化湿开胃;行气宽中;温脾;止泻;安胎。主治湿阻气滞;脘腹胀痛;不思饮食;恶心呕吐;腹痛泄泻;妊娠恶阻;胎动不安。《纲目》载:“补肺醒脾,养胃益肾,理元气,通滞气,散寒饮胀痞,噎膈呕吐,止女子崩中,除咽喉口齿浮热,化铜铁骨哽。”现代医学研究证实,砂仁能加强肠管收缩,大剂量时对肠管有抑制作用,表现张力降低,部分或完全拮抗乙酰胆碱,增进肠道运动,明显抑制血小板聚集,明显对抗胶原和肾上腺素的诱发作用。
甘草:味甘;性平。归心;肺;脾;胃经。补脾益气;清热解毒;祛痰止咳;缓急止痛;调和诸药。主治脾胃虚弱;倦怠乏力;心悸气短;咳嗽痰多;脘腹四脚挛急疼痛;痈肿疮毒;缓解药物毒性。《本草纲目》载:“诸药中甘草为君。治七十二种乳石毒,解一千二百般草本毒,调和从药有功。”现代医学研究证实,甘草有较强的解毒作用,还有抗溃疡、抗炎症、镇痉镇咳、降血压、降血脂、抗癌作用,广泛用于治疗咽喉炎、喉炎、气管炎、支气管炎、哮喘、咳嗽、咳血等疾病,此外还具有抗胃溃疡、抗胃炎作用。
本发明与现有技术相比,具有以下有益效果:清热解毒、健脾祛湿、祛瘀通络、固涩收敛。临床上根据不同症状辨证施治,该药适用于治疗急、慢性放射性直肠炎患者。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料药组成及重量为:
地榆85g土茯苓81g防风79g厚朴76g
枳壳72g薏苡仁68g银柴胡65g仙鹤草61g
白芍59g白术58g陈皮53g黄柏49g
槐花49g青木香43g当归42g三棱38g
红花35g砂仁34g甘草31g。
本发明药物使用方法的工艺步骤为:
1)按照上述重量g数称取各类药材,混合均匀后加入300ml水,煎煮2次,滤掉药渣即得所述中药组合物汤剂。
2)将步骤1)所得的汤剂取250ml,早晚各服用100ml,余下50ml加温至38℃~40℃于晚间睡前患者排空大便后灌肠。灌肠时取左侧卧位,臀部抬高约10cm,肛管插入10-15cm,将上述50ml药液灌入。灌肠后用消毒纱布置于肛门处以防药液流出,保留30min以上,每晚一次。
3)用药疗程为10天1疗程,巩固治疗需要2-3疗程。
注意事项:服用本发明期间,忌食辛辣生冷食物。
实施例2
本发明药物有效成分的原料药组成及重量为:
地榆83g土茯苓81g防风77g厚朴75g
枳壳72g薏苡仁68g银柴胡65g仙鹤草62g
白芍61g白术58g陈皮55g黄柏51g
槐花46g青木香44g当归42g三棱40g
红花37g砂仁32g甘草31g。
本实施例的药物使用方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料药组成及重量为:
地榆85g土茯苓79g防风76g厚朴75g
枳壳70g薏苡仁68g银柴胡67g仙鹤草64g
白芍60g白术55g陈皮52g黄柏50g
槐花48g青木香43g当归43g三棱39g
红花36g砂仁31g甘草31g。
本实施例的药物使用方法工艺步骤及用法用量与实施例1相同。
以上显示和描述了本发明的基本原理、主要特征和本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的要本发明范围内。本发明要求保护范围由所附的权利要求书用其等效物界定。
临床资料:
1、病例选择
选择我院或外院确诊的放射性直肠炎患者122例临床观察,病人随机分成两组。治疗组61例,年龄30~75岁,平均年龄50岁。对照组61例,年龄30~75岁,平均年龄50岁。两组资历基本一致,无显著差异,具有可比性。
2、治疗组患者服用本发明所述的一种中药组合物加水300ml煎煮2次后,取250ml,早晚各服100ml,余下50ml加温至38℃-40℃于晚间睡前患者排空大便后予以灌肠,灌肠时取左侧卧位,臀部抬高约10cm,肛管插入4-5cm,将上述50ml药液灌入。灌肠后用消毒纱布置于肛门处以防药液流出,保留30min以上,每晚一次,10天为1个疗程,连用两个疗程。
对照组采用抗生素静脉注射,同时给予2%普鲁卡因40ml,庆大霉素8万U,地塞米松5mg,蒙脱石散剂3g,生理盐水10ml保留灌肠,每晚一次,10天为1个疗程,连用两个疗程。
3、疗效判定:
疗效标准参照《疾病临床诊断和疗效标准》制定:
治愈:自觉症状消失,大便隐血阴性,直肠镜检查肠粘膜恢复正常;
好转:自觉症状减轻,大便隐血弱阳性,直肠病变变平变小,肠腔狭窄较前好转。
无效:自觉症状及检查均为改善。
4、结果
治疗组中治愈34例,好转21例,无效6例,治愈率56%,总有效率92%。
对照组中治愈26例,好转22例,无效13例,治愈率43%,总有效率80%。
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
1、孙XX,女,62岁,2012年11月宫颈癌术后1个月,放射性治疗16天,大便带脓血2天,有少量粘液,伴腹泻水样便,用氟哌酸治疗效果不佳。直肠镜检查:见肠壁充血、肿胀呈赤褐色。给予暂停止放疗。患者要求服本发明中药8剂后无血便出现,停用仙鹤草,继续服该药15剂,临床症状完全消失,半年后随访未再复发。
2、王XX,男,62岁,2013年6月因前列腺癌术后3月,前列腺放射治疗12天。出现间歇性血便2天,直肠镜检查:可见肠壁充血、溃疡。经住院治疗西药治疗,效果不佳,患者要求服本发明中药20剂,临床症状完全消失,直肠镜检查正常,至今未复发。
3、姜XX,女,51岁,2012年11月就诊。患者因宫颈癌术后放疗第2个周,出现血便,腹痛、腹泻,全身乏力,直肠镜下可见肠壁充血,给予止血药和消炎药治疗,病情反复,患者要求服本发明中药14剂后,临床症状完全消失,半年后随访未再复发。
4、魏XX,女,51岁,2013年8月就诊。患者因肛管直肠癌放疗后2周,出现便中带脓血,腹痛,乏力等症状,直肠镜检查:可见肠壁充血、溃疡。患者要求服本发明中药13剂,临床症状完全消失,直肠镜检查正常,至今未复发。
5、严XX,女,58岁,2012年7月就诊。反复腹泻,便脓血20余年,时泻时止,便中时有脓血,大便时无不爽之象,纳呆,乏力,面色无华,消瘦,舌淡,苔白,脉虚无力,反复腹泻,患者要求服本发明中药12剂后,临床症状完全消失,半年后随访未再复发。
几年来,使用本发明的中药治疗放射性直肠炎,结果显示本发明的中药具有见效快,副总用小,作用范围广、用量小等优点,是一种治疗放射性直肠炎的优选药物。
Claims (4)
1.一种用于放射性直肠炎治疗与护理的中药组方,其特征在于,所述药物有效成分的原料药组成及重量份数为:
2.一种用于放射性直肠炎治疗与护理的中药组方,其特征在于,所述药物有效成分的原料药组成及重量份数为:
3.一种用于放射性直肠炎治疗与护理的中药组方,其特征在于,所述药物有效成分的原料药组成及重量份数为:
4.一种用于放射性直肠炎治疗与护理的中药组方,其特征在于,所述药物有效成分的原料药组成及重量份数为:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510874373.6A CN105288433A (zh) | 2015-12-02 | 2015-12-02 | 一种用于放射性直肠炎治疗与护理的中药组方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510874373.6A CN105288433A (zh) | 2015-12-02 | 2015-12-02 | 一种用于放射性直肠炎治疗与护理的中药组方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105288433A true CN105288433A (zh) | 2016-02-03 |
Family
ID=55186711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510874373.6A Pending CN105288433A (zh) | 2015-12-02 | 2015-12-02 | 一种用于放射性直肠炎治疗与护理的中药组方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105288433A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117323368A (zh) * | 2023-10-27 | 2024-01-02 | 中山大学附属第五医院 | 一种治疗放射性直肠炎用中药及其制备方法 |
-
2015
- 2015-12-02 CN CN201510874373.6A patent/CN105288433A/zh active Pending
Non-Patent Citations (2)
| Title |
|---|
| 国家食品药品监督管理局: "关于加强广防己等6种药材及其制剂监督管理的通知", 《国家食品药品监督管理总局网站》 * |
| 国家食品药品监督管理局编者: "药品不良反应信息通报(第6期) 警惕含马兜铃酸中药的安全性问题、左旋咪唑等咪唑类驱虫药与脑炎综合征、盐酸芬氟拉明的心血管系统严重不良反应", 《国家食品药品监督管理总局网站》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117323368A (zh) * | 2023-10-27 | 2024-01-02 | 中山大学附属第五医院 | 一种治疗放射性直肠炎用中药及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104055965A (zh) | 一种治疗痔疮的内服药物及其应用 | |
| CN103705751B (zh) | 用于治疗风湿腰痛的中药组合物及其制备方法 | |
| CN100417403C (zh) | 治疗癌症的中药 | |
| CN101095923B (zh) | 一种治疗宫外孕的中药 | |
| CN101607011B (zh) | 一种治疗胆囊炎术后并发症的中药药物 | |
| CN102961506A (zh) | 一种用于功能性子宫出血护理的药物及制备方法 | |
| CN105663980A (zh) | 一种治疗慢性胃炎的新型中药组合物及制备方法 | |
| CN102784229A (zh) | 一种治疗运动损伤和风湿型骨关节病外用熏洗中药 | |
| CN102772534B (zh) | 一种用于治疗痔疮的中药膏 | |
| CN105288071A (zh) | 一种用于痔疮治疗及术后护理的中药组方及制备方法 | |
| CN104689279A (zh) | 一种用于子宫腺肌病的中药制剂及制备方法 | |
| CN104587206A (zh) | 治疗褥疮的药物及制备方法 | |
| CN104225490A (zh) | 一种治疗胆囊炎的中药 | |
| CN104147516A (zh) | 一种治疗骨髓炎的中药组方 | |
| CN102935190B (zh) | 一种用于阑尾炎术前术后护理的药丸及制备方法 | |
| CN103610772B (zh) | 治疗脑血栓的中药 | |
| CN105288433A (zh) | 一种用于放射性直肠炎治疗与护理的中药组方 | |
| CN114533831A (zh) | 一种具有温中散寒祛湿,活血通络止痛的中药组合物及其热奄包 | |
| CN105232849A (zh) | 一种治疗烧伤的膏药 | |
| CN105343522A (zh) | 一种治疗慢性便秘的药物及其制备方法 | |
| CN104771538A (zh) | 一种用于肝癌疼痛的中药制剂及制备方法 | |
| CN104324114A (zh) | 治疗痢疾的中药制剂 | |
| CN104306612A (zh) | 一种治疗痔疮的外用熏洗液 | |
| CN104189608B (zh) | 一种治疗复发性口腔溃疡的中药制剂及制备方法 | |
| CN103751752B (zh) | 一种治疗痢疾的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160203 |
|
| RJ01 | Rejection of invention patent application after publication |